Probity Advisors, Inc. Amgen Inc Transaction History

Probity Advisors, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $195,973 - $217,418	-839 Closed	0 $0
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $40,831 - $47,582	-184 Reduced 17.99%	839 $209,000
Q3 2020 Nov 09, 2020	SELL	$234.65 - $260.95 $13,609 - $15,135	-58 Reduced 5.37%	1,023 $260,000
Q2 2020 Aug 03, 2020	SELL	$197.81 - $242.74 $7,912 - $9,709	-40 Reduced 3.57%	1,081 $255,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $8,565 - $11,359	-47 Reduced 4.02%	1,121 $227,000
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $11,352 - $14,592	-60 Reduced 4.89%	1,168 $282,000
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $34,299 - $41,098	-197 Reduced 13.82%	1,228 $238,000
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $10,335 - $12,115	-62 Reduced 4.17%	1,425 $263,000
Q1 2019 Apr 29, 2019	SELL	$180.87 - $203.88 $6,149 - $6,931	-34 Reduced 2.24%	1,487 $283,000
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $2,140 - $2,499	12 Added 0.8%	1,521 $296,000
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $21,493 - $24,231	-116 Reduced 7.14%	1,509 $313,000
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $3,321 - $3,730	-20 Reduced 1.22%	1,625 $300,000
Q1 2018 Apr 16, 2018	SELL	$169.43 - $198.0 $13,893 - $16,236	-82 Reduced 4.75%	1,645 $280,000
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $29,538 - $33,003	175 Added 11.28%	1,727 $300,000
Q3 2017 Oct 27, 2017	BUY	$167.29 - $191.0 $259,634 - $296,432	1,552	1,552 $289,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Probity Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Probity Advisors, Inc. with notifications on news.